Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups

Vaccine

Volumn 32, Issue 35, 2014, Pages 4443-4449

  Nunes, Baltazar ^a   Machado, Ausenda ^a   Guiomar, Raquel ^a   Pechirra, Pedro ^a   Conde, Patrícia ^a   Cristovão, Paula ^a   Falcão, Isabel ^b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Unidade de Apoio às Emergências em Saúde Pública Direção Geral da Saúde   (Portugal)

Author keywords

Case test negative control study; Effectiveness; Influenza vaccine; Other respiratory virus

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; ANIMAL; CLINICAL TRIAL; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; MULTICENTER STUDY; PRESCHOOL CHILD; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904394778     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.053     Document Type: Article

References (37)

1. Valenciano M., Kissling E., Team I.- Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013, 18(7):3.
2. Kissling E., Valenciano M., Larrauri A., Oroszi B., Cohen J.M., Nunes B., et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013, 18(5).
3. Nunes B., Machado A., Pechirra P., Falcão I., Gonçalves P., Conde P., et al. Efectividade da vacina antigripal na época 2010-2011 em Portugal: resultados do projeto EuroEVA. Rev Port Med Geral Fam 2012, 28:271-284.
4. Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. MMWR Morb Mortal Wkly Rep 2013, 62(7):119-123.
5. Skowronski D.M., Janjua N.Z., De Serres G., Dickinson J.A., Winter A-L., Mahmud S.M., et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill 2013, 18(5).
6. Kelly H.A., Sullivan S.G., Grant K.A., Fielding J.E. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza Other Resp Viruses 2012.
7. Nicoll A., Sprenger M. Low effectiveness undermines promotion of seasonal influenza vaccine. Lancet Infect Dis 2013, 13(1):7-9.
8. WHO. World Health Organization. Recommended composition of influenza virus vaccines for use in the northern hemisphere 2013-2014 influenza season; 2013 [cited 2014 13 May]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201302_qanda_recommendation.pdf?ua=1.
9. WHO. World Health Organization. Recommended composition of influenza virus vaccines for use in the southern hemisphere 2014 influenza season; 2013 [cited 2014 13 May]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201309_qanda_recommendation.pdf?ua=1.
10. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31(17):2165-2168.
11. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
12. Valenciano M., Kissling E., Ciancio B.C., Moren Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010, 28(46):7381-7388.
13. Puig-Barbera J., Díez-Domingo J., Arnedo-Pena A., Ruiz-García M., Pérez-Vila S., Micó-Esparza J.L., et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012, 30(39):5714-5720.
14. Kelly H., Jacoby P., Dixon G.A., Carcione D., Williams S., Moore H.C., et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011, 30(2):107-111.
15. Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology 2012, 23(6):930-931.
16. Cowling B.J., Fang V.J., Nishiura H., Chan K.H., Ng S., Ip D.K., et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012, 54(12):1778-1783.
17. Sundaram M.E., McClure D.L., VanWormer J.J., Friedrich T.C., Meece J.K., Belongia E.A. Influenza Vaccination is Not Associated with Detection of Non-Influenza Respiratory Viruses in Seasonal Studies of Influenza Vaccine Effectiveness. Clin Infect Dis 2013.
18. Blyth C.C., Jacoby P., Effler P.V., Kelly H., Smith D.W., Robins C., et al. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 2014.
19. Kissling E., Valenciano M., Falcão J., Larrauri A., Widgren K., Pitigoi D., et al. I-MOVE towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-2009. Euro Surveill 2009, 14(44).
20. Kissling E., Valenciano M. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012, 17(15).
21. Valenciano M., Kissling E., Cohen J-M., Oroszi B., Barret A-S., Rizzo C., et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011, 8(1):e1000388.
22. Jorge I.N.d.S.D.R. Médicos-Sentinela. O que se fez em 2007.[Portuguese GP Network. What was done in 2007] 2009, Instituto Nacional de Saúde Dr. Ricardo Jorge [National Institute of Health Dr. Ricardo Jorge], Lisbon. I. Jorge (Ed.).
23. Commission E. Commission Decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (2009/363/EC) 2009, Publications Office of the European Union, Luxembourg. E. Commission (Ed.).
24. WHO, World Health Organization. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Global Influenza Surveillance Network; 2011.
25. Ellis J.S., Curran M.D. Simultaneous molecular detection and confirmation of influenza AH5, with internal control. Methods Mol Biol 2011, 665:161-181.
26. Gunson R.N., Collins T.C., Carman W.F. Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol 2005, 33(4):341-344.
27. Tiveljung-Lindell A., Rotzén-Ostlund M., Gupta S., Ullstrand R., Grillner L., Zweygberg-Wirgart B., et al. Development and implementation of a molecular diagnostic platform for daily rapid detection of 15 respiratory viruses. J Med Virol 2009, 81(1):167-175.
28. Wang R., Taubenberger J.K. Methods for molecular surveillance of influenza. Expert Rev Anti Infect Ther 2010, 8(5):517-527.
29. Couch R.B., Douglas R.G., Fedson D.S., Kasel J.A. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis 1971, 124(5):473-480.
30. Suess T., Remschmidt C., Schink S.B., Schweiger B., Heider A., Milde J., et al. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011. PLoS One 2012, 7(12):e51653.
31. Pinto C.S., Nunes B., Branco M.J., Falcão J.M. Trends in influenza vaccination coverage in Portugal from 1998 to 2010: effect of major pandemic threats. BMC Public Health 2013, 13(1):1130.
32. Sousa Uva M., Nunes B., Roquette R., Silva S., Contreiras T., Matias-Dias C. Vacinação antigripal da população portuguesa na época 2012-2013 - Estudo na amostra ECOS: relatório. Relatórios Científicos e Técnicos 2013, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa. INSA (Ed.).
33. Dianzani F. Viral interference and interferon. Ric Clin Lab 1975, 5(3):196-213.
34. Guiomar R., Conde P., Cristovão P., Pechirra P., Nunes B. Programa Nacional de Vigilância da Gripe: Relatório da época 2012/2013, in Relatórios científicos e técnicos. Relatórios Científicos e Técnicos 2013, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa. INSA (Ed.).
35. Kelly H., Barry S., Laurie K., Mercer G. Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection. Euro Surveill 2010, 15(47).
36. Dierig A., Heron L.G., Lambert S.B., Yin J.K., Leask J., Chow M.Y., et al. Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness. Influenza Other Respir Viruses 2014, 8(3):293-301.
37. Valenciano M., Ciancio B. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill 2012, 17(39).